Posts by Russell Jenkins, MD, PhD
-
Revealing the Mechanisms of CAR T-Cell Therapy Resistance in Solid Tumors
Physician-scientists at Massachusetts General Hospital use patient-derived tumor models to decode mechanisms of CAR T-cell therapy resistance in solid tumors.
-
Revolutionizing Cancer Immunotherapy for Melanoma and Beyond
Researchers at Massachusetts General Hospital won a Breakthrough Award to enhance personalized approaches to immunotherapy for metastatic melanoma.
Biography
Russell Jenkins, MD, PhD, is an investigator in the Krantz Family Center for Cancer Research at the Mass General Cancer Center, and an assistant professor of Medicine at Harvard Medical School.
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
